KM
Kevin McCulloch
See Remarks

Kevin McCulloch insider trades: Xeris Biopharma Holdings (XERS) stock buys and sales

See Remarks, Xeris Biopharma Holdings Last trade Nov 5, 2026 18 Form 4 filings
$1.8M
Sold, last 12 months
7 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026XERS↓ Sell$312K
Nov 2, 2026XERS↓ Sell$153K
Oct 1, 2026XERS↓ Sell$141K
Sep 28, 2026XERS↓ Sell$250K
Sep 1, 2026XERS↓ Sell$127K
Aug 3, 2026XERS↓ Sell$120K
Jul 1, 2026XERS↓ Sell$723K
Jun 13, 2025XERS↑ Buy$109K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other XERS insiders

Open-market trades in the last 12 months

About Kevin McCulloch's insider trades

Kevin McCulloch is See Remarks at Xeris Biopharma Holdings (XERS). Since Jun 13, 2025, Kevin has reported 1 open-market purchase worth $109K and 7 sales worth $1.8M on SEC Form 4. In the last 12 months: 7 sales ($1.8M).

Their filings also include shares withheld for taxes (7 filings), grants and awards (3 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XERS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.